ReadYourDNA

Trimipramine

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Trimipramine

What it is

Trimipramine is a tricyclic antidepressant (TCA) with a strong calming, sleep-promoting effect, because it also blocks histamine. It is used for depression, especially when sleep problems or anxiety are prominent. It is sold as Surmontil and Stangyl, among other names.

How genes come into it

Trimipramine is broken down by the liver enzymes CYP2C19 and CYP2D6. People with little or no CYP2D6 activity build up higher levels, and CYP2C19 variants shift how much is turned into its active breakdown product. CPIC has published a guideline on CYP2D6 and CYP2C19 for the tricyclics, including trimipramine, and the US FDA lists an effect on drug levels. A few other genes have been studied, with weaker evidence.

Published guidelines

Clinical guidelines that name a gene for Trimipramine. They sort people into groups by the gene copies they carry.

CPIC guideline: CYP2C19, CYP2D6. CYP2D6: No Result, activity score 0.0, activity score 0.25, activity score 0.5, activity score 0.75, activity score 1.0, activity score 1.25, activity score 1.5, activity score 1.75, activity score 2.0, activity score 2.25, activity score 2.5, activity score 2.75, activity score 3.0, ≥3.0, ≥3.25, ≥3.5, ≥3.75, activity score 4.0, ≥4.0, ≥5.0, ≥6.0, n/a, xN combinations · CYP2C19: Ultrarapid Metabolizer, Rapid Metabolizer, Normal Metabolizer, Likely Intermediate Metabolizer, Intermediate Metabolizer, Likely Poor Metabolizer, Poor Metabolizer, Indeterminate, No Result. Strong. 2017.

US FDA: CYP2D6. CYP2D6 activity score 0 to 6 or more. Data that Demonstrate a Potential Impact on Pharmacokinetic Properties Only.

What research found

Every published finding on gene variants and Trimipramine. Upload your DNA file to see which of these rows apply to you.

Rated evidence (3 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

CYP2D6 CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6: Level 1A · replicated. Metabolism/PK: Mental Disorders. 4.

CYP2C19 CYP2C19*1, CYP2C19*2: Level 1A · replicated. Metabolism/PK. 2.

CYP2C9 CYP2C9*1, CYP2C9*3: Level 3. Other. 1.

Metabolism (9 findings)

Studies of how quickly the body processes this medication.

CYP2C19 CYP2C19*1, CYP2C19*2: CYP2C19 *2 is associated with decreased metabolism of trimipramine in healthy individuals as compared to CYP2C19 *1/*1.

CYP2C19 CYP2C19*1, CYP2C19*2: CYP2C19 *2 is associated with decreased clearance of trimipramine in healthy individuals as compared to CYP2C19 *1/*1.

CYP2C9 CYP2C9*3: CYP2C9 *3/*3 is associated with decreased metabolism of trimipramine in healthy individuals.

CYP2D6 CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5: CYP2D6 *3/*3 + *3/*5 + *4/*4 (assigned as poor metabolizer phenotype) are associated with decreased metabolism of trimipramine in healthy individuals as compared to CYP2D6 *1/*2xN.

Response (2 findings)

Studies of how well it worked in people carrying a variant.

ABCB1 rs2032583: Genotype GG is not associated with response to amitriptyline, citalopram, escitalopram, nortriptyline, paroxetine, Selective serotonin reuptake inhibitors, sertraline, trimipramine or venlafaxine in people with Bipolar Disorder as compared to genotypes AA + AG.

ABCB1 rs2235015: Genotype AA is not associated with response to amitriptyline, citalopram, escitalopram, nortriptyline, paroxetine, Selective serotonin reuptake inhibitors, sertraline, trimipramine or venlafaxine in people with Bipolar Disorder as compared to genotypes AA + AC.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Amitriptyline (TCAs)

Anafranil (TCAs)

Norpramin (TCAs)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com